| Identification | Back Directory | [Name]
Apigenin 7-O-methylglucuronide | [CAS]
53538-13-9 | [Synonyms]
Apigenin 7-O-methylglucuronide
Apigenin-7-O-β-D-glucuronidemethylester
β-D-Glucopyranosiduronic acid, 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, methyl ester
(2S,3S,4S,5R,6S)-Methyl 3,4,5-trihydroxy-6-((5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chroMen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylate | [Molecular Formula]
C22H20O11 | [MOL File]
53538-13-9.mol | [Molecular Weight]
460.39 |
| Hazard Information | Back Directory | [Description]
Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content.
Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling. | [Uses]
Apigenin 7-O-methylglucuronide is a natural product[1]. | [References]
[1] Harvey A L. Natural products in drug discovery[J]. Drug discovery today, 2008, 13(19-20): 894-901. DOI:10.1016/j.drudis.2008.07.004 |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|